A PET imaging study of the vascular disruptive agent OXi4503 to confirm in vivo mechanism of action in a phase I trial

P. M. Price, M.-C. Asselin, B. Koetz, C. Dickinson, N. Charnley, P. Lorigan, J. Valle, M. Stratford, G. Rustin, A. Saleem

    Research output: Contribution to journalComment/debatepeer-review

    Original languageEnglish
    JournalJ Clin Oncol
    Issue number15
    Publication statusPublished - May 2009

    Cite this